Study on the liver stiffness evaluated by shear wave elastography and Fibroscan for grading hepatic fibrosis and portal hypertension

Study on the liver stiffness evaluated by shear wave elastography and Fibroscan for grading hepatic fibrosis and portal hypertension - Elastography for grading fibrosis and portal hypertension

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022838

Enrollment

150

Registered

2016-06-22

Start date

2015-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis, liver cirrhosis

Interventions

Shear wave elastography in the right hepatic lobe using the abdominal ultrasound apparatus (for patients with chronic hepatitis or liver cirrhosis) Live biopsy (for patients with chronic hepatitis or

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic hepatitis or liver cirrhosis in our hospital Patients whose document consent was obtained under their free will and understandings, after receiving sufficient explanation on the medical condition and treatment Patients who are able to be followed up in our hospital

Exclusion criteria

Exclusion criteria: Patients with thrombosis in portal vein, splenic vein, and/or the superior mesenteric vein Patients with liver tumors Patients who have diseases causing the abnormality in the number of platelets other than liver cirrhosis Patients with idiopathic portal hypertension or extrahepatic portal obstruction Patients with severe heart disease or lung disease Pregnant patients Patients whom the doctors have determined to be inappropriate

Design outcomes

Primary

Measure	Time frame
Diagnostic ability of 2D-SWE for cirrhosis	—

Countries

Japan

Contacts

Public ContactHitoshi MARUYAMA

Chiba University Graduate School of Medicine Department of Gastroenterology and Nephrology

maru-cib@umin.ac.jp+81-(0)43-226-2083

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026